COMMUNIQUÉS West-GlobeNewswire
-
Senti Bio Announces Reverse Stock Split
17/11/2026 -
Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke™ Scans as Commercial Expansion Accelerates
17/11/2026 -
Medicenna Therapeutics Reports Second Quarter Fiscal 2027 Financial Results and Provides Corporate Update
17/11/2026 -
Nine-month interim report (Q3) 2026 (unaudited)
17/11/2026 -
Davion Healthcare Plc Provides Shareholders with Guidance on Direct Registration and Confirmation of Share Ownership
17/11/2026 -
Weight Watchers Announces Discounted Prepayment Solicitation to Utilize Up to $10 Million to Reduce Term Loan Debt
17/11/2026 -
Acoramidis Was Associated with Lower Risk of Worsening Heart Failure Versus Tafamidis in Real-World Study and Reduced Heart Failure Events Within One Month in ATTRibute-CM
17/11/2026 -
Noom Launches OpenRx, a New Peptide and Preventive Health Brand
17/11/2026 -
Hyalex Orthopaedics Announces First Commercial Case with the Slalom MTP Implant for Hallux Rigidus
17/11/2026 -
Greenwich LifeSciences Announces Acceptance of Abstracts at SABCS 2026
17/11/2026 -
Cognition Therapeutics Announces CTAD Poster Highlighting Screening Efficiencies with p-Tau217 in the Ongoing Phase 2 START Study
17/11/2026 -
Eikon Therapeutics Announces Clearance to Proceed with First-in-Human Phase 1/2 Study for Novel Androgen Receptor Antagonist EIK1006 in Advanced Metastatic Prostate Cancer
17/11/2026 -
Burning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026
17/11/2026 -
Biocomposites welcomes new clinical pathway for local infection management in severe pressure ulcers
17/11/2026 -
CancerVax Successfully Kills Cancer Cells in Landmark Test
17/11/2026 -
Cancer Research UK and Dewpoint Therapeutics partner to advance potential first-in-class MYC condensate modulator into clinical development
17/11/2026 -
ProMIS Neurosciences Licenses Next-Generation TXP1 Brain-Selective Shuttling Technology from Ossianix to Expand PMN310 Franchise and Pipeline
17/11/2026 -
Commit Biologics announces final close of $60 million seed financing to advance complement-powered immune engagers toward the clinic
17/11/2026 -
Rapid Nutrition Announces SystemLS AI Mobile App to Accelerate International Growth and Create Recurring Subscription Revenue Opportunity
17/11/2026
Pages